Literature DB >> 27084891

Hepatic Cytochrome P450 Activity, Abundance, and Expression Throughout Human Development.

Natalie C Sadler1, Premchendar Nandhikonda1, Bobbie-Jo Webb-Robertson1, Charles Ansong1, Lindsey N Anderson1, Jordan N Smith1, Richard A Corley1, Aaron T Wright2.   

Abstract

Cytochrome P450s are oxidative metabolic enzymes that play critical roles in the biotransformation of endogenous compounds and xenobiotics. The expression and activity of P450 enzymes varies considerably throughout human development; the deficit in our understanding of these dynamics limits our ability to predict environmental and pharmaceutical exposure effects. In an effort to develop a more comprehensive understanding of the ontogeny of P450 enzymes, we employed a multi-omic characterization of P450 transcript expression, protein abundance, and functional activity. Modified mechanism-based inhibitors of P450s were used as chemical probes for isolating active P450 proteoforms in human hepatic microsomes with developmental stages ranging from early gestation to late adult. High-resolution liquid chromatography-mass spectrometry was used to identify and quantify probe-labeled P450s, allowing for a functional profile of P450 ontogeny. Total protein abundance profiles and P450 rRNA was also measured, and our results reveal life-stage-dependent variability in P450 expression, abundance, and activity throughout human development and frequent discordant relationships between expression and activity. We have significantly expanded the knowledge of P450 ontogeny, particularly at the level of individual P450 activity. We anticipate that these results will be useful for enabling predictive therapeutic dosing, and for avoiding potentially adverse and harmful reactions during maturation from both therapeutic drugs and environmental xenobiotics.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27084891      PMCID: PMC4931891          DOI: 10.1124/dmd.115.068593

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  49 in total

Review 1.  Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants.

Authors:  D W Nebert
Journal:  Clin Chem Lab Med       Date:  2000-09       Impact factor: 3.694

2.  Expression of CYP2D6 in developing human liver.

Authors:  J M Treluyer; E Jacqz-Aigrain; F Alvarez; T Cresteil
Journal:  Eur J Biochem       Date:  1991-12-05

Review 3.  Activity-based protein profiling: from enzyme chemistry to proteomic chemistry.

Authors:  Benjamin F Cravatt; Aaron T Wright; John W Kozarich
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

4.  Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice.

Authors:  Susan Ritger Crowell; Arun K Sharma; Shantu Amin; Jolen J Soelberg; Natalie C Sadler; Aaron T Wright; William M Baird; David E Williams; Richard A Corley
Journal:  Toxicol Sci       Date:  2013-06-06       Impact factor: 4.849

5.  Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome.

Authors:  J M Tréluyer; H Benech; I Colin; A Pruvost; G Chéron; T Cresteil
Journal:  Pediatr Res       Date:  2000-05       Impact factor: 3.756

6.  Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.

Authors:  D Lacroix; M Sonnier; A Moncion; G Cheron; T Cresteil
Journal:  Eur J Biochem       Date:  1997-07-15

7.  In vitro age-dependent enzymatic metabolism of chlorpyrifos and chlorpyrifos-oxon in human hepatic microsomes and chlorpyrifos-oxon in plasma.

Authors:  Jordan Ned Smith; Charles Timchalk; Michael J Bartels; Torka S Poet
Journal:  Drug Metab Dispos       Date:  2011-04-26       Impact factor: 3.922

8.  Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.

Authors:  C Cazeneuve; G Pons; E Rey; J M Treluyer; T Cresteil; G Thiroux; P D'Athis; G Olive
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

9.  Multiplexed activity-based protein profiling of the human pathogen Aspergillus fumigatus reveals large functional changes upon exposure to human serum.

Authors:  Susan D Wiedner; Kristin E Burnum; LeeAnna M Pederson; Lindsey N Anderson; Suereta Fortuin; Lacie M Chauvigné-Hines; Anil K Shukla; Charles Ansong; Ellen A Panisko; Richard D Smith; Aaron T Wright
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

Review 10.  Cooperative properties of cytochromes P450.

Authors:  Ilia G Denisov; Daniel J Frank; Stephen G Sligar
Journal:  Pharmacol Ther       Date:  2009-06-23       Impact factor: 12.310

View more
  28 in total

1.  Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development.

Authors:  Sarah Dubaisi; Kathleen G Barrett; Hailin Fang; Jorge Guzman-Lepe; Alejandro Soto-Gutierrez; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2018-06-01       Impact factor: 3.922

2.  Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male Mice.

Authors:  Alexa Torrens; Valentina Vozella; Hannah Huff; Brandon McNeil; Faizy Ahmed; Andrea Ghidini; Stephen V Mahler; Marilyn A Huestis; Aditi Das; Daniele Piomelli
Journal:  J Pharmacol Exp Ther       Date:  2020-04-28       Impact factor: 4.030

3.  High-Fat Diets Alter the Modulatory Effects of Xenobiotics on Cytochrome P450 Activities.

Authors:  Natalie C Sadler; Bobbie-Jo M Webb-Robertson; Therese R Clauss; Joel G Pounds; Richard Corley; Aaron T Wright
Journal:  Chem Res Toxicol       Date:  2018-05-04       Impact factor: 3.739

Review 4.  Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.

Authors:  Deepak Ahire; Laken Kruger; Sheena Sharma; Vijaya Saradhi Mettu; Abdul Basit; Bhagwat Prasad
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

5.  Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues.

Authors:  Joshua F Robinson; Emily G Hamilton; Juleen Lam; Hao Chen; Tracey J Woodruff
Journal:  Placenta       Date:  2020-08-06       Impact factor: 3.481

6.  Newborn Mice Lacking the Gene for Cyp1a1 Are More Susceptible to Oxygen-Mediated Lung Injury, and Are Rescued by Postnatal β-Naphthoflavone Administration: Implications for Bronchopulmonary Dysplasia in Premature Infants.

Authors:  Paramahamsa Maturu; Yanhong Wei-Liang; Weiwu Jiang; Lihua Wang; Krithika Lingappan; Roberto Barrios; Yao Liang; Bhagavatula Moorthy; Xanthi I Couroucli
Journal:  Toxicol Sci       Date:  2017-05-01       Impact factor: 4.849

7.  Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A.

Authors:  Kristina Jonsson-Schmunk; Romi Ghose; Maria A Croyle
Journal:  Expert Rev Vaccines       Date:  2021-03-18       Impact factor: 5.217

8.  Expression of cytochrome P450 isozyme transcripts and activities in human livers.

Authors:  Jie Liu; Yuan-Fu Lu; J Christopher Corton; Curtis D Klaassen
Journal:  Xenobiotica       Date:  2020-12-28       Impact factor: 1.908

9.  Exposure to an Environmental Mixture of Polycyclic Aromatic Hydrocarbons Induces Hepatic Cytochrome P450 Enzymes in Mice.

Authors:  Ethan G Stoddard; Subhasree Nag; Jude Martin; Kimberly J Tyrrell; Teresa Gibbins; Kim A Anderson; Anil K Shukla; Richard Corley; Aaron T Wright; Jordan N Smith
Journal:  Chem Res Toxicol       Date:  2021-09-02       Impact factor: 3.973

10.  Hepatic Transcriptomic Patterns in the Neonatal Rat After Pentabromodiphenyl Ether Exposure.

Authors:  June K Dunnick; Keith R Shockley; Daniel L Morgan; Gregory S Travlos; Kevin Gerrish; Thai-Vu T Ton; Ralph Wilson; Sukhdev S Brar; Amy E Brix; Suramya Waidyanatha; Esra Mutlu; Arun Kumar R Pandiri
Journal:  Toxicol Pathol       Date:  2019-12-12       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.